← Back to Screener
Chemed Corporation (CHE)
Price$422.84
Value ScoreD
Growth ScoreD
Momentum ScoreC
Favorite Metrics
Price vs S&P 500 (26W)-16.61%
Price vs S&P 500 (4W)-3.97%
VGM Score37.10
Market Capitalization$5.66B
P/E Ratio (Annual)21.34x
Indicated Dividend Yield (Annual)0.56%
All Metrics
P/CF (Annual)14.58x
Book Value / Share (Quarterly)$64.15
P/TBV (Annual)6.76x
Indicated Dividend (Annual)$2.40
Revenue Growth (3Y)5.82%
Cash Flow / Share (Quarterly)$28.53
Payout Ratio (TTM)12.53%
Price vs S&P 500 (YTD)-11.27%
Gross Margin (TTM)32.38%
Net Profit Margin (TTM)10.23%
EPS (TTM)$18.36
10-Day Avg Trading Volume0.20M
EPS Excl Extra (TTM)$18.36
Revenue Growth (5Y)4.00%
EPS (Annual)$18.34
Dividend / Share (Annual)$2.24
ROI (Annual)26.78%
Gross Margin (Annual)32.54%
Net Profit Margin (5Y Avg)11.84%
Cash / Share (Quarterly)$1.28
P/E Basic Excl Extra (TTM)21.79x
Revenue Growth QoQ (YoY)1.63%
EPS Growth (5Y)-1.20%
P/E Normalized (Annual)21.34x
ROA (Last FY)17.24%
Revenue Growth TTM (YoY)2.07%
EBITD / Share (TTM)$27.74
ROE (5Y Avg)30.60%
Operating Margin (TTM)12.91%
Cash Flow / Share (Annual)$23.74
P/B Ratio6.67x
P/B Ratio (Quarterly)6.51x
Net Income / Employee (Annual)$16,800
EV / Revenue (TTM)2.26x
Net Interest Coverage (TTM)79.50x
ROA (TTM)16.20%
EPS Growth QoQ (YoY)-0.35%
EV / EBITDA (TTM)14.59x
EPS Incl Extra (Annual)$18.34
Current Ratio (Annual)1.05x
Quick Ratio (Quarterly)0.72x
3-Month Avg Trading Volume0.25M
52-Week Price Return-25.61%
EV / Free Cash Flow (Annual)17.65x
P/E Incl Extra (TTM)21.79x
Revenue / Employee (TTM)$160,700
Tangible BV / Share (Quarterly)$58.06
P/S Ratio (Annual)2.24x
Asset Turnover (Annual)1.64x
52-Week High$578.57
Operating Margin (5Y Avg)15.12%
EPS Excl Extra (Annual)$18.34
CapEx CAGR (5Y)1.32%
Tangible BV CAGR (5Y)2.74%
26-Week Price Return-0.68%
Quick Ratio (Annual)0.90x
13-Week Price Return7.51%
Total Debt / Equity (Annual)0.01x
Current Ratio (Quarterly)0.85x
Enterprise Value$5.75B
Revenue / Share Growth (5Y)6.65%
Asset Turnover (TTM)1.58x
Book Value / Share Growth (5Y)4.74%
Revenue / Employee (Annual)$160,000
Inventory Turnover (Annual)216.93x
Pretax Margin (Annual)14.06%
Cash / Share (Annual)$5.43
3-Month Return Std Dev41.66%
Gross Margin (5Y Avg)34.96%
Net Income / Employee (TTM)$16,400
EBITDA CAGR (5Y)-2.02%
EBITDA Interim CAGR (5Y)1.41%
ROE (Last FY)27.08%
Net Interest Coverage (Annual)70.61x
EPS Basic Excl Extra (Annual)$18.34
P/FCF (TTM)15.01x
Receivables Turnover (TTM)10.13x
EV / Free Cash Flow (TTM)15.23x
Total Debt / Equity (Quarterly)0.12x
EPS Incl Extra (TTM)$18.36
Receivables Turnover (Annual)14.30x
ROI (TTM)24.65%
Dividend Growth Rate (5Y)11.06%
P/S Ratio (TTM)2.23x
Pretax Margin (5Y Avg)15.55%
Revenue / Share (Annual)$174.96
Tangible BV / Share (Annual)$65.40
Forward P/E16.86x
Free OCF CAGR (5Y)-5.44%
Price vs S&P 500 (52W)-53.81%
P/E Ratio (TTM)21.79x
EPS Growth TTM (YoY)-10.58%
Year-to-Date Return-0.34%
5-Day Price Return-2.95%
EPS Normalized (Annual)$18.34
ROA (5Y Avg)17.80%
Net Profit Margin (Annual)10.48%
Month-to-Date Return0.34%
Cash Flow / Share (TTM)$20.11
EBITD / Share (Annual)$27.88
EPS Growth (3Y)3.53%
Operating Margin (Annual)13.37%
LT Debt / Equity (Annual)0.00x
P/CF (TTM)12.76x
ROI (5Y Avg)27.72%
P/E Excl Extra (TTM)21.79x
LT Debt / Equity (Quarterly)0.11x
EPS Basic Excl Extra (TTM)$18.36
P/TBV (Quarterly)7.19x
Payout Ratio (Annual)11.95%
P/B Ratio (Annual)6.19x
Dividend / Share (TTM)$2.34
Inventory Turnover (TTM)229.10x
Pretax Margin (TTM)13.73%
Book Value / Share (Annual)$71.43
Price vs S&P 500 (13W)-2.24%
Net Margin Growth (5Y)-7.36%
Dividend Yield (TTM)0.57%
Beta0.54x
P/FCF (Annual)17.39x
Revenue / Share (TTM)$185.58
ROE (TTM)25.33%
52-Week Low$365.21
vGradeD
gGradeD
mGradeC
vgmGradeD
Show chart for
Earnings Surprise History
Q1 265.65est. 5.36
Analyst Recommendations
Feb 2026
Mar 2026
Apr 2026
May 2026
4.13
3.75
3.75
3.75
Industry Peers — Home Health Care(7)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
CHEChemed Corporation | D | D | C | $422.84 |
| BTSGBrightSpring Health Services, Inc. Common Stock | D | B | A | $59.98 |
| BTSGUBrightSpring Health Services, Inc. Tangible Equity Unit | D | B | A | $198.86 |
| OPCHOption Care Health, Inc. Common Stock | B | C | D | $20.46 |
| ADUSAddus HomeCare Corp. | C | B | D | $89.45 |
| AVAHAveanna Healthcare Holdings Inc. Common Stock | B | B | C | $6.67 |
| AHCOAdaptHealth Corp. Common Stock | B | C | C | $9.93 |
| EHABEnhabit, Inc. | B | D | B | $13.80 |
About
Chemed Corp operates two primary businesses through its subsidiaries: VITAS, a leading provider of hospice and palliative care services, and Roto-Rooter, a provider of plumbing and drain cleaning services. VITAS generates the majority of the company's revenue and serves patients with terminal illnesses through a network of healthcare professionals. The company is positioned as a diversified holding company focused on maximizing shareholder value.